Hampar L. Karageozian
Fondateur chez Allegro Ophthalmics LLC
Profil
Hampar L.
Karageozian is the founder who has founded two companies.
VitreoRetinal Technologies, Inc. was founded in 1999, where he held the title of Chief Executive Officer from 1999 to 2010.
Allegro Ophthalmics LLC was founded in 1993, where he held the title of Executive Director & Chief Technical Officer.
Mr. Karageozian's former jobs include Director at VG Life Sciences, Inc., Chief Technology Officer at ISTA Pharmaceuticals, Inc. from 1994 to 1999, Senior VP-Research & Development at Allergan Pharmaceuticals Ltd., Inc. from 2010 to 2012, and Senior Vice President at R&D Services, Inc. Mr. Karageozian's education history includes an undergraduate degree from Massachusetts Institute of Technology.
Postes actifs de Hampar L. Karageozian
| Sociétés | Poste | Début |
|---|---|---|
Allegro Ophthalmics LLC
 Allegro Ophthalmics LLC BiotechnologyHealth Technology Allegro Ophthalmics LLC operates as a biopharmaceutical company. It focuses on the development of novel integrin-regulating therapies for the treatment of ocular diseases. The company was founded by Hampar Karageozian and John Park and is headquartered in San Juan Capistrano, CA. | Fondateur | 01/01/1993 |
Anciens postes connus de Hampar L. Karageozian
| Sociétés | Poste | Fin |
|---|---|---|
ISTA Pharmaceuticals, Inc.
 ISTA Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology ISTA Pharmaceuticals, Inc. was incorporated as Advanced Corneal Systems, Inc. in California in February 1992 to discover, develop, and market new remedies for diseases and conditions of the eye. In March 2000, the company changed its name to ISTA Pharmaceuticals, Inc. It reincorporated, in Delaware, in August 2000. BROMDAY, BEPREVE, ISTALOL, VITRASE, XIBROM (bromfenac ophthalmic solution), XIBROM, T-PRED, PROLENSA, BEPOSONE, BEPOMAX, ISTA, ISTA Pharmaceuticals, Inc. and the ISTA logo are its trademarks, either owned or under license. Ista is commercial-stage, multi-specialty pharmaceutical company, which develops, markets, and sells its own products in the United States and Puerto Rico. Its products are intended to treat allergy and serious diseases of the eye and include therapies for ocular inflammation and pain, glaucoma, dry eye, and ocular and nasal allergies. | Directeur Technique/Scientifique/R&D | 01/01/1999 |
R&D Services, Inc.
 R&D Services, Inc. Engineering & ConstructionIndustrial Services Part of Essar Group, R & D Services, Inc. is a company that provides technical design, installation, and maintenance services for premise cabling. The company is based in Westborough, MA. R&D Services, Inc. was acquired by Black Box Corp., part of Essar Group from January 08, 2019 on January 24, 2000. | Corporate Officer/Principal | - |
VitreoRetinal Technologies, Inc.
 VitreoRetinal Technologies, Inc. Medical SpecialtiesHealth Technology Vitreoretinal Technologies, Inc. was a pharmaceutical company. It was used to develop and commercialize innovative therapeutic systems for the treatment of serious ocular diseases. The company was founded in July 1999 and was headquartered in Irvine, CA. | Directeur Général | - |
Allergan Pharmaceuticals Ltd., Inc.
 Allergan Pharmaceuticals Ltd., Inc. Pharmaceuticals: MajorHealth Technology Allergan Pharmaceuticals Ltd., Inc. develops and distributes pharmaceuticals, biologics and medical devices. It imports and exports pharmaceutical products. The company is located in Irvine, CA | Directeur Technique/Scientifique/R&D | - |
| VG LIFE SCIENCES INC. | Directeur des opérations | 21/07/2009 |
Formation de Hampar L. Karageozian
| Massachusetts Institute of Technology | Undergraduate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| VG LIFE SCIENCES INC. | Health Technology |
| Entreprise privées | 5 |
|---|---|
ISTA Pharmaceuticals, Inc.
ISTA Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology ISTA Pharmaceuticals, Inc. was incorporated as Advanced Corneal Systems, Inc. in California in February 1992 to discover, develop, and market new remedies for diseases and conditions of the eye. In March 2000, the company changed its name to ISTA Pharmaceuticals, Inc. It reincorporated, in Delaware, in August 2000. BROMDAY, BEPREVE, ISTALOL, VITRASE, XIBROM (bromfenac ophthalmic solution), XIBROM, T-PRED, PROLENSA, BEPOSONE, BEPOMAX, ISTA, ISTA Pharmaceuticals, Inc. and the ISTA logo are its trademarks, either owned or under license. Ista is commercial-stage, multi-specialty pharmaceutical company, which develops, markets, and sells its own products in the United States and Puerto Rico. Its products are intended to treat allergy and serious diseases of the eye and include therapies for ocular inflammation and pain, glaucoma, dry eye, and ocular and nasal allergies. | Health Technology |
VitreoRetinal Technologies, Inc.
VitreoRetinal Technologies, Inc. Medical SpecialtiesHealth Technology Vitreoretinal Technologies, Inc. was a pharmaceutical company. It was used to develop and commercialize innovative therapeutic systems for the treatment of serious ocular diseases. The company was founded in July 1999 and was headquartered in Irvine, CA. | Health Technology |
Allergan Pharmaceuticals Ltd., Inc.
Allergan Pharmaceuticals Ltd., Inc. Pharmaceuticals: MajorHealth Technology Allergan Pharmaceuticals Ltd., Inc. develops and distributes pharmaceuticals, biologics and medical devices. It imports and exports pharmaceutical products. The company is located in Irvine, CA | Health Technology |
R&D Services, Inc.
R&D Services, Inc. Engineering & ConstructionIndustrial Services Part of Essar Group, R & D Services, Inc. is a company that provides technical design, installation, and maintenance services for premise cabling. The company is based in Westborough, MA. R&D Services, Inc. was acquired by Black Box Corp., part of Essar Group from January 08, 2019 on January 24, 2000. | Industrial Services |
Allegro Ophthalmics LLC
Allegro Ophthalmics LLC BiotechnologyHealth Technology Allegro Ophthalmics LLC operates as a biopharmaceutical company. It focuses on the development of novel integrin-regulating therapies for the treatment of ocular diseases. The company was founded by Hampar Karageozian and John Park and is headquartered in San Juan Capistrano, CA. | Health Technology |
